Article: MedaSorb Technologies MSBT.OB Draws Closer to Completion of Human Clinical Trials.

TapeBeat.com, the news and research portal for the serious bio-tech investor in conjunction with the Farseers Group is proud to profile one of the most exciting up and coming biotech companies, MedaSorb Technologies (MSBT.OB), which is perfectly poised to realize exponential growth (see also TapeBeat.com).

MedaSorb Technologies is a medical device company that operates exclusively through its wholly owned subsidiary, CytoSorbents Inc. Their flagship medical device, the "CytoSorb™", is a patented blood purification device that uses state of the art resin technology to remove toxins from the blood, allowing the recirculation of clean blood back into the body. ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!